News
GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom ...
In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs ...
It's not every day that Health and Human Services Secretary Robert F. Kennedy Jr. and Independent Senators Bernie Sanders and Angus King would agree on, well, anything. But when it comes to the ...
AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...
6d
BUCKSCO.Today on MSNGlaxosmithkline Gets Approval for First-of-its-Kind Lupus TreatmentGlaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...
It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. GlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older adults ...
The Food and Drug Administration on Monday granted marketing approval to GlaxoSmithKline for Priorix, a vaccine to prevent measles, mumps and rubella in individuals a year or older.
As per the deal, GlaxoSmithKline will pay the vaccine maker up to $1.2 billion more if certain milestones are arrived at in Affinivax's impending clinical trials for a new pneumococcal vaccine.
GlaxoSmithKline has been called GSK for years — but the pharma company officially made the move to simplify the name this week. GlaxoSmithKline is now officially just GSK, the company announced Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results